Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGM-101 in Colorectal Cancer Surgery
NCT03659448Phase 3Recruiting
- Sponsor
- SurgiMab
- Start
- Jun 2019
- Primary completion
- Nov 2024
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs)
- Countries
- 4
01
Overview
A Phase 3 trial of sgm-101 in colorectal cancer (CRC), sponsored by SurgiMab. Started Jun 2019; status: recruiting.
02
Drugs
sgm-101
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03659448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03659448.